Chronic Diphenhydramine Use Monitoring

Introduction to Diphenhydramine

First-generation antihistamines like diphenhydramine are generally recommended only for short courses (2-3 days) due to tolerance development and side effects, as suggested by the American Academy of Sleep Medicine 1
Diphenhydramine is classified as "Not Recommended" for treating either sleep onset or sleep maintenance insomnia in clinical practice guidelines by the American Academy of Sleep Medicine 2

Patients on chronic diphenhydramine are at higher risk for anticholinergic side effects, including cognitive impairment, especially in older adults with pre-existing conditions such as prostatic hypertrophy, elevated intraocular pressure, and cognitive impairment, according to the Journal of Allergy and Clinical Immunology 3
Sedation/drowsiness is reported in approximately 50% of users, and anticholinergic effects such as dry mouth, blurred vision, and urinary retention should be monitored clinically, as noted by the Journal of Allergy and Clinical Immunology 3

For insomnia, consider medications specifically approved for this indication rather than diphenhydramine, as recommended by the American Academy of Sleep Medicine 2
Second-generation antihistamines (e.g., cetirizine, loratadine, fexofenadine) are preferred for chronic use due to fewer side effects, although no specific citation is provided for this statement, it is implied as a better alternative to diphenhydramine.